Pfizer reported a dip in profits Tuesday, driven partly by lower sales of Covid-19 therapeutic drug Paxlovid, as it ...

"I prepare these differently from the box instructions," she tells her audience. She cooks the potatoes in butter (or margarine) with milk and water on the stove for 10 minutes before pouring them ...

Nirmatrelvir-ritonavir was beneficial for COVID-19 management in patients with chronic kidney disease or kidney failure, significantly reducing the risk of mortality and hospital admission.

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.

PLpro’s cousin, a protein called Mpro, executes a similar function. The antiviral Paxlovid inhibits Mpro, which helps prevent severe sickness. Loading But PLpro has another critical function ...

Antiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving long COVID symptoms, according to a new study published in The Lancet Infectious Diseases on April 3. The ...

The Cyprus Securities and Exchange Commission (CySEC) has issued a new circular addressed to all Cyprus Investment Firms (CIFs) regarding the updated procedure for reporting cross-border ...

Antiviral medications nirmatrelvir/ritonavir (Paxlovid) were not effective in relieving Long COVID symptoms, according to a new study published in The Lancet Infectious Diseases on April 3. “This is ...

While currently approved therapies for COVID-19 like Paxlovid target a critical coronavirus protein known as Mpro, WEHI researchers identified another protein, termed PLpro, as a promising drug ...

The world-first study also found the compound can treat acute COVID with better efficacy than Paxlovid – the leading treatment currently approved for COVID-19. It’s hoped the results could ...